Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

5.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.6K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

4.1K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.1K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How many protein pairs can we chemically target?

Drug discovery today·2026
Same author

Novel drug targets in 2025.

Nature reviews. Drug discovery·2026
Same author

Target identification and assessment in the era of AI.

Nature reviews. Drug discovery·2026
Same author

The Common Fund Data Ecosystem (CFDE).

bioRxiv : the preprint server for biology·2026
Same author

CACHE Challenge #3: Targeting the Nsp3 Macrodomain of SARS-CoV-2.

Journal of chemical information and modeling·2026
Same author

Bigger is faster in the adaptive immune response.

Scientific reports·2025

Related Experiment Video

Updated: Aug 26, 2025

Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity
09:00

Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity

Published on: December 31, 2015

26.7K

Agent-based modeling predicts RAC1 is critical for ovarian cancer metastasis.

Melanie Rivera1, Leslie Toledo-Jacobo1, Elsa Romero1

  • 1Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque, NM 87131.

Molecular Biology of the Cell
|October 6, 2022
PubMed
Summary

Rac1 protein is crucial for ovarian cancer metastasis, controlling cell adhesion and invasion. Targeting Rac1 could impact tumor cell spread and survival during metastasis.

More Related Videos

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
12:42

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression

Published on: August 28, 2012

15.1K
Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.8K

Related Experiment Videos

Last Updated: Aug 26, 2025

Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity
09:00

Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity

Published on: December 31, 2015

26.7K
Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
12:42

Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression

Published on: August 28, 2012

15.1K
Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.8K

Area of Science:

  • Oncology
  • Cell Biology
  • Computational Biology

Background:

  • Metastasis is a complex process involving multiple steps.
  • Rac1 is a known regulator of cell motility and invasion.

Purpose of the Study:

  • To identify the rate-limiting steps in ovarian cancer metastasis.
  • To investigate the role of Rac1 in the metastatic cascade.
  • To develop a computational model of ovarian cancer metastasis.

Main Methods:

  • Ovarian cancer cell and animal models were used.
  • Rac1 expression was manipulated.
  • Quantitative measurements of adhesion, invasion, and tumor growth were performed.
  • An agent-based computational model was developed and parameterized.

Main Results:

  • Rac1 overexpression enhanced cell adhesion, invasion, and intravasation.
  • Increased Rac1 activity led to greater dissemination of tumor cells.
  • Cancer cell crowding at blood vessels decreased distant niche colonization.
  • Modeling predictions were validated in animal studies.

Conclusions:

  • Rac1 critically regulates ovarian cancer cell adhesion, intravasation, and survival.
  • Targeting Rac1 may offer therapeutic strategies for ovarian cancer metastasis.
  • Intravasation sites and cell survival are key rate-limiting factors in metastasis.